Hydra Biosciences Company
Hydra Biosciences develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using ion channels.
Founded Date:
2001
Employee Number:
11-50
Funding Status:
Late Stage Venture
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Estimated Revenue:
$1M to $10M